Chasity Freeman

Chasity Freeman, MBA, currently serves as Quality Assurance Lead at Gilead Sciences since April 2022. Prior to this role, Chasity Freeman was employed at Sarepta Therapeutics as Senior Specialist in Gene Therapy Quality Assurance from August 2021 to March 2022, and at bluebird bio from December 2018 to July 2021, where responsibilities included Associate Scientist II in Analytical Method Development and QC Analyst II for Bioassay/Biochemistry. Experience also includes positions at Biogen, where Chasity Freeman worked as Associate Scientist in Quality Control and Analytical Development from December 2016 to December 2018, and at LabCorp as a Laboratory Technologist in Molecular Infectious Disease from January 2015 to November 2016. Chasity Freeman holds a Master of Business Administration from Walden University and a Bachelor of Science in Biology with a Chemistry Minor from Western Carolina University.